COAGADEX

Serial Number 85660445
Registration 4291786
800

Registration Progress

Application Filed
Jun 25, 2012
Under Examination
Approved for Publication
Dec 4, 2012
Published for Opposition
Dec 4, 2012
Registered
Feb 19, 2013

Trademark Image

COAGADEX

Basic Information

Serial Number
85660445
Registration Number
4291786
Filing Date
June 25, 2012
Registration Date
February 19, 2013
Published for Opposition
December 4, 2012
Renewal Date
February 19, 2023
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
800
Status Date
Aug 18, 2023
Registration
Registered
Classes
005

Rights Holder

Bio Products Laboratory Limited

99
Address
Dagger Lane, Elstree
Hertfordshire WD63BX
GB

Ownership History

Bio Products Laboratory Limited

Original Applicant
99
Hertfordshire GB

Bio Products Laboratory Limited

Owner at Publication
99
Hertfordshire GB

Bio Products Laboratory Limited

Original Registrant
99
Hertfordshire GB

Legal Representation

Attorney
Timothy J. Lyden

USPTO Deadlines

Next Deadline
2777 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2013-02-19)
Due Date
February 19, 2033
Grace Period Ends
August 19, 2033

Application History

35 events
Date Code Type Description
Aug 18, 2023 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 18, 2023 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Aug 18, 2023 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Aug 18, 2023 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Jan 31, 2023 E89R I TEAS SECTION 8 & 9 RECEIVED
Feb 19, 2022 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Sep 21, 2021 NA15 E SEC. 15 ACKNOWLEDGEMENT - E-MAILED
Sep 20, 2021 15AK O REGISTERED - SEC. 15 ACKNOWLEDGED
Sep 15, 2021 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 2, 2021 E15R I TEAS SECTION 15 RECEIVED
Jul 14, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 14, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 14, 2021 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 14, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 19, 2019 8.OK O REGISTERED - SEC. 8 (6-YR) ACCEPTED
Mar 19, 2019 NAS8 E NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Mar 16, 2019 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 19, 2019 ES8R I TEAS SECTION 8 RECEIVED
Feb 19, 2018 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 19, 2013 R.PR A REGISTERED-PRINCIPAL REGISTER
Dec 4, 2012 PUBO A PUBLISHED FOR OPPOSITION
Dec 4, 2012 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 14, 2012 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 31, 2012 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 30, 2012 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 19, 2012 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 19, 2012 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 18, 2012 ALIE A ASSIGNED TO LIE
Oct 4, 2012 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Aug 31, 2012 CNSL R SUSPENSION LETTER WRITTEN
Aug 31, 2012 GNSL F LETTER OF SUSPENSION E-MAILED
Aug 31, 2012 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 25, 2012 DOCK D ASSIGNED TO EXAMINER
Jul 2, 2012 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 28, 2012 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations being or containing Factor X, also known as thrombokinase, for use in the treatment of blood clotting disorders
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005

USPTO Documents

Loading USPTO documents...